Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-276-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: other routes
Administrative data
- Endpoint:
- acute toxicity: other routes
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable well documented study report which meets basic scientific principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 963
- Report date:
- 1963
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- BASF-Test: The substance was injected into the peritoneal cavity. Young adult laboratory mice were purchased from breeder. Usually the source and strain of animals were not documented. Several groups of 5 mice per sex and dose were treated simultaneously with preparations of the test substance in suitable vehicle. The concentrations of these preparations were used to achieve comparable volumes per kg body weight. Group-wise documentation of clinical signs was performed over the 7 day study period. Body weight was determined before the start of the study only, as it was needed for determination of dose.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Methylenediphenyl diisocyanate
- EC Number:
- 247-714-0
- EC Name:
- Methylenediphenyl diisocyanate
- Cas Number:
- 26447-40-5
- IUPAC Name:
- 1,1'-methylenebis(2-isocyanatobenzene)
- Details on test material:
- - Name of test material (as cited in study report): Diphenylmethandiisocyanat (MDI), roh
- Physical state: liquid
- Analytical purity: test substance comprises of 4 isomers of MDI in concentration of 5, 15, 25 and 55%
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Mean body weight at study initiation:
119 mg/kg bw: 33.1 g (30-38 g)
238 mg/kg bw: 35.8 g (31-40 g)
476 mg/kg bw: 34.7 g (30-39 g)
1904 mg/kg bw: 34.5 g (31-37 g)
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- other: aqueous emulsion with Traganth
- Details on exposure:
- DOSAGE PREPARATION:
- Stock solutions prepared:
2% for the 119, 238 and 476 mg/kg bw dose group;
16% for the 1904 mg/kg bw dose group,
- Dose volume applied:
5 ml/kg bw of the 2% stock solution for the 119 mg/kg bw dose group,
10 ml/kg bw of the 2% stock solution for the 238 mg/kg bw dose group,
20 ml/kg bw of the 2% stock solution for the 476 mg/kg bw dose group,
8 ml/kg bw of the 16% stock solution for the 1904 mg/kg bw dose group. - Doses:
- 100, 200, 400 and 1600 ml/kg bw (corresponding to 119, 238, 476 and 1904 mg/kg bw) Calculation in mg/kg bw based on density of the test substance (1.19 g/L).
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 7 days
- Frequency of observations and weighing: mortality and clinical signs of toxicity were observed several times on the application day and thereafter once each working day, body weights were only recorded at the beginning of the study
- Necropsy of survivors performed: yes
Results and discussion
Effect levels
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 298 mg/kg bw
- Mortality:
- No mortalities in the lowest dose group, 4/10 died in the 238 mg/kg bw dose group, 7/10 died in the 476 mg/kg bw dose group, and 8/9 died in the 1904 mg/kg bw dose group. One animal died due to injection injury in the 1904 mg/kg bw dose group.
- Clinical signs:
- Immediately after application, uneasiness, agitation, hollow-back like appearance, accelerated respiration and later silent behaviour with jerky respiration were observed. In next days, animals were in poor general condition and were not without sysmptoms till 7 days post application.
- Body weight:
- not reported
- Gross pathology:
- In the deceased animals, substance rests and sticky organs were observed in the abdominal cavity. The medulla renalis of kidney was hyperemic in 5 animals. In the sacrificed animals, substance rests and sticky organs were observed in the abdominal cavity with barely appreciable fibrinous exudate.
Any other information on results incl. tables
Mortalities of rats after ip application of MDI
Dose (mg/kg bw) |
Died within |
|||
1 hr |
24 hr |
48 hr |
7 days |
|
119 |
0/9* |
5/9 |
8/9 |
8/9 |
238 |
0/10 |
2/10 |
7/10 |
7/10 |
476 |
0/10 |
0/10 |
2/10 |
4/10 |
1904 |
0/10 |
0/10 |
0/10 |
0/10 |
*: one animal died due to injection injury
LD50: original value reported was 250 ml/kg bw (corresponding to 298 mg/kg bw).
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.